Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model

K Rosenke; A Okumura; MC Lewis; F Feldmann; K Meade-White; WF Bohler; A Griffin; R Rosenke; C Shaia; MA Jarvis; H Feldmann

doi:10.1101/2022.02.22.481491

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model

K Rosenke, A Okumura, MC Lewis, F Feldmann, K Meade-White, WF Bohler, A Griffin, R Rosenke, C Shaia, MA Jarvis, H Feldmann

School of Biomedical Sciences

Research output: Working paper › Preprint

Original language	English
Number of pages	0
DOIs	https://doi.org/10.1101/2022.02.22.481491
Publication status	Published - 24 Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1101/2022.02.22.481491

Cite this

@techreport{0fdbe28136d0459a81b55cc1072a2ced,

title = "Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model",

author = "K Rosenke and A Okumura and MC Lewis and F Feldmann and K Meade-White and WF Bohler and A Griffin and R Rosenke and C Shaia and MA Jarvis and H Feldmann",

year = "2022",

month = feb,

day = "24",

doi = "10.1101/2022.02.22.481491",

language = "English",

type = "WorkingPaper",

}

TY - UNPB

T1 - Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model

AU - Rosenke, K

AU - Okumura, A

AU - Lewis, MC

AU - Feldmann, F

AU - Meade-White, K

AU - Bohler, WF

AU - Griffin, A

AU - Rosenke, R

AU - Shaia, C

AU - Jarvis, MA

AU - Feldmann, H

PY - 2022/2/24

Y1 - 2022/2/24

U2 - 10.1101/2022.02.22.481491

DO - 10.1101/2022.02.22.481491

M3 - Preprint

BT - Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model

ER -